1. Home
  2. FBRX vs AGCC Comparison

FBRX vs AGCC Comparison

Compare FBRX & AGCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Forte Biosciences Inc.

FBRX

Forte Biosciences Inc.

HOLD

Current Price

$19.12

Market Cap

487.2M

Sector

Health Care

ML Signal

HOLD

AGCC

Agencia Comercial Spirits Ltd Class A Ordinary Shares

N/A

Current Price

$17.12

Market Cap

438.9M

ML Signal

N/A

Company Overview

Basic Information
Metric
FBRX
AGCC
Founded
N/A
2020
Country
United States
Taiwan
Employees
N/A
23
Industry
Biotechnology: Pharmaceutical Preparations
Beverages (Production/Distribution)
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
487.2M
438.9M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
FBRX
AGCC
Price
$19.12
$17.12
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$67.00
N/A
AVG Volume (30 Days)
178.8K
21.5K
Earning Date
05-14-2026
05-23-2026
Dividend Yield
N/A
N/A
EPS Growth
61.30
N/A
EPS
N/A
N/A
Revenue
$36,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$168.97
Revenue Growth
N/A
N/A
52 Week Low
$7.78
$4.23
52 Week High
$35.80
$25.73

Technical Indicators

Market Signals
Indicator
FBRX
AGCC
Relative Strength Index (RSI) 32.53 51.05
Support Level $18.18 $13.30
Resistance Level $34.44 $18.11
Average True Range (ATR) 2.09 1.54
MACD -0.22 -0.13
Stochastic Oscillator 5.88 38.44

Price Performance

Historical Comparison
FBRX
AGCC

About FBRX Forte Biosciences Inc.

Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.

About AGCC Agencia Comercial Spirits Ltd Class A Ordinary Shares

Agencia Comercial Spirits Ltd specializes in the procurement, distribution, and sale of high-quality whiskies, including both bottled and cask whisky in both Taiwan and international markets. The company's product portfolio includes the distribution of bottled whisky, raw cask whisky, and proprietary brand whisky.

Share on Social Networks: